Evaluating a polypill for managing coronary risk factors
Official title: Cross-over Analysis of the Control of Coronary Risk Factors and Level of Platelet Inhibition With a Polypill
Run by Fundación EPIC · NCT05030818 · Data updated 2026-11-12
This study tests if a combined pill with three heart medications can help people with coronary artery disease manage their blood pressure and cholesterol better than taking the medications separately.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 88 (estimated) |
| Sponsor | Fundación EPIC Academic / other |
| Locations | 1 site (Gijón, Principality of Asturias) |
| Status | Recruiting |
| Started | October 14, 2022 |
| Main results expected | March 30, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | August 5, 2025 |
| Trial ID | NCT05030818 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old currently using the Trinomia® polypill for secondary prevention of cardiovascular disease.
✕Probably not a fit
Patients with contraindications to any component of the polypill or those with life expectancy limitations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open-label, randomized, cross-over study investigates the effectiveness of a polypill containing acetylsalicylic acid, ramipril, and atorvastatin in patients with coronary artery disease. Participants will alternate between taking the polypill and the individual components over a six-month period, with the primary focus on measuring systolic blood pressure and LDL cholesterol levels. The study aims to determine if the polypill improves adherence and health outcomes compared to taking the medications separately. Monthly follow-up visits will ensure proper monitoring and data collection.
Why it matters
Potential benefit: If successful, this study could enhance treatment adherence and improve cardiovascular health outcomes for patients with coronary artery disease.
How similar studies have gone: While there have been successful studies on polypills for cardiovascular prevention, this specific cross-over design comparing the polypill to its individual components is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients over 18 years of age. Patients under treatment with the Trinomia® polypill in any of its presentations for indication of secondary prevention and who can make the 6 visits necessary to complete the study. Patients who sign the Informed Consent. Exclusion Criteria: Patients who do not sign the informed consent. Patients with an inability to understand and comply with the protocol. Patients with contraindication to any component of the polypill. Patients who are already participating in another clinical trial. Patients with any condition that limits life expectancy to \<1 year. Patients with programmed coronary revascularization. Patients with coronary stent implantation in the last 12 months. Patients treated with any antithrombotic drug in addition to acetylsalicylic acid, that is, low molecular weight heparin, P2Y12 receptor inhibitors, or oral anticoagulants.
Where it's running
-
Hospital Universitario de Cabueñes
Gijón, Principality of Asturias, Spain Recruiting
Study contacts
- Principal investigator: Iñigo Lozano, MD, PHD — Hospital de Cabueñes, Gijon
- Study coordinator: Iñigo Lozano Martinez-Luengas, MD, PHD
- Email: inigo.lozano@gmail.com
- Phone: +34630901145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.